These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8520461)

  • 1. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
    De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
    Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP; Macdonald RL
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
    Levillain O; Marescau B; de Deyn PP
    Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
    Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
    Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency.
    De Deyn PP; Marescau B; Cuykens JJ; Van Gorp L; Lowenthal A; De Potter WP
    Clin Chim Acta; 1987 Jul; 167(1):81-8. PubMed ID: 3665089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney.
    Levillain O; Marescau B; Possemiers I; De Deyn P
    Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy.
    Marescau B; Qureshi IA; De Deyn P; Letarte J; Ryba R; Lowenthal A
    Clin Chim Acta; 1985 Feb; 146(1):21-7. PubMed ID: 3987036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous guanidino compounds as uremic neurotoxins.
    De Deyn PP; D'Hooge R; Van Bogaert PP; Marescau B
    Kidney Int Suppl; 2001 Feb; 78():S77-83. PubMed ID: 11168988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for guanidino compounds in the brain.
    Hiramatsu M
    Mol Cell Biochem; 2003 Feb; 244(1-2):57-62. PubMed ID: 12701810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidino compounds as uremic (neuro)toxins.
    De Deyn PP; Vanholder R; Eloot S; Glorieux G
    Semin Dial; 2009; 22(4):340-5. PubMed ID: 19708978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals.
    Marescau B; Deshmukh DR; Kockx M; Possemiers I; Qureshi IA; Wiechert P; De Deyn PP
    Metabolism; 1992 May; 41(5):526-32. PubMed ID: 1588833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of guanidino compounds in rat and rabbit.
    Levillain O; Marescau B; De Deyn PP
    J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):561-70. PubMed ID: 9080382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents.
    Zounr RA; Khuhawar MY; Jahangir TM; Alamgir M
    Anal Sci; 2016; 32(2):141-6. PubMed ID: 26860556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.